or Try an Advanced Search...

    Technical Analysis for CNSP - CNS Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.12 -4.31% -0.01
    CNSP closed down 4.31 percent on Friday, November 22, 2024, on 54 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical CNSP trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Shooting Star Candlestick Bearish -4.31%
    Crossed Above 50 DMA Bullish -4.31%
    Pocket Pivot Bullish Swing Setup -4.31%
    Wide Bands Range Expansion -4.31%
    Gapped Up Strength -4.31%
    Upper Bollinger Band Touch Strength -4.31%
    Older End-of-Day Signals for CNSP ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 13 hours ago
    Down 5% about 16 hours ago
    Down 3% about 16 hours ago
    Fell Below 50 DMA about 16 hours ago
    Shooting Star Candlestick Entry about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CNSP Chart by TradingView
    Basic chart:

    Profile

    CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. The company was founded in 2017 and is based in Houston, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Oncology Blastoma Glioblastoma Stage Pharmaceutical Brain Tumor Evofosfamide Central Nervous System Tumors

    Is CNSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
    Nov 15 CNS Pharmaceuticals reports Q3 results
    Nov 15 CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
    Nov 4 CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
    Nov 1 CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
    Oct 23 CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Oct 10 CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
    Oct 8 CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
    Sep 23 CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
    See more CNSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 115.995
    52 Week Low 0.0955
    Average Volume 18,132,171
    200-Day Moving Average 5.86
    50-Day Moving Average 0.13
    20-Day Moving Average 0.12
    10-Day Moving Average 0.12
    Average True Range 0.02
    RSI (14) 47.92
    ADX 38.77
    +DI 32.43
    -DI 18.90
    Chandelier Exit (Long, 3 ATRs) 0.12
    Chandelier Exit (Short, 3 ATRs) 0.17
    Upper Bollinger Bands 0.14
    Lower Bollinger Band 0.10
    Percent B (%b) 0.59
    BandWidth 33.14
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.003
    Fundamentals Value
    Market Cap 1.05 Million
    Num Shares 8.43 Million
    EPS -7.60
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 0.00
    Price-to-Book 4.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.15
    Resistance 3 (R3) 0.14 0.13 0.14
    Resistance 2 (R2) 0.13 0.13 0.14 0.14
    Resistance 1 (R1) 0.13 0.13 0.13 0.13 0.14
    Pivot Point 0.12 0.12 0.12 0.12 0.12
    Support 1 (S1) 0.11 0.11 0.12 0.12 0.11
    Support 2 (S2) 0.10 0.11 0.11 0.11
    Support 3 (S3) 0.10 0.10 0.11
    Support 4 (S4) 0.10